Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013, Article ID 923129, 4 pages
http://dx.doi.org/10.1155/2013/923129
Case Report

DiGeorge Syndrome Presenting as Hypocalcaemia-Induced Seizures in Adulthood

Department of Surgery, Mater Dei Hospital, Msida MSD 2090, Malta

Received 14 January 2013; Accepted 9 May 2013

Academic Editor: André Mégarbané

Copyright © 2013 Adrian Zammit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Di George, H. W. Lischner, C. Dacou, and J. B. Arey, “Absence of the thymus,” The Lancet, vol. 1, no. 7504, p. 1387, 1967. View at Google Scholar · View at Scopus
  2. D. I. Wilson, I. E. Cross, C. Wren et al., “Minimum prevalence of chromosome 22q11 deletions,” The American Journal of Human Genetics, vol. 55, p. A169, 1994. View at Google Scholar
  3. K. Devriendt, J. P. Fryns, G. Mortier, M. N. Van Thienen, and K. Keymolen, “The annual incidence of DiGeorge/velocardiofacial syndrome,” Journal of Medical Genetics, vol. 35, no. 9, pp. 789–790, 1998. View at Google Scholar · View at Scopus
  4. H. B. Robinson, “DiGeorge's or the III-IV pharyngeal pouch syndrome: pathology and a theory of pathogenesis,” Perspectives in Pediatric Pathology, vol. 2, pp. 173–206, 1975. View at Google Scholar · View at Scopus
  5. K. Mølsted, M. Boers, and I. Kjär, “The morphology of the sella turcica in velocardiofacial syndrome suggests involvement of a neural crest developmental field,” American Journal of Medical Genetics A, vol. 152, no. 6, pp. 1450–1457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Moss, P. P. Wang et al., “Characteristic cognitive profile in patients with a 22q11 deletion: verbal IQexceeds nonverbal IQ,” American Journal of Human Genetics, vol. 57, no. 4, p. A42, 1995. View at Google Scholar
  7. A. K. Ryan, J. A. Goodship, D. I. Wilson et al., “Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study,” Journal of Medical Genetics, vol. 34, no. 10, pp. 798–804, 1997. View at Google Scholar · View at Scopus
  8. M. Sieberer, I. Runte, A. Wilkening, B. Pabst, M. Ziegenbein, and H. Haltenhof, “Spectrum of neuropsychiatric features associated with velocardiofacial syndrome (deletion 22q11.2),” Fortschritte der Neurologie Psychiatrie, vol. 74, no. 5, pp. 263–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. C. Murphy, L. A. Jones, and M. J. Owen, “High rates of schizophrenia in adults with velo-cardio-facial syndrome,” Archives of General Psychiatry, vol. 56, no. 10, pp. 940–945, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kao, J. Mariani, D. M. McDonald-McGinn et al., “Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion,” American Journal of Medical Genetics, vol. 129, no. 1, pp. 29–34, 2004. View at Google Scholar · View at Scopus
  11. S. C. Butts, “The facial phenotype of the velo-cardio-facial syndrome,” International Journal of Pediatric Otorhinolaryngology, vol. 73, no. 3, pp. 343–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. F. Cuneo, “22q11.2 deletion syndrome: diGeorge, velocardiofacial, and conotruncal anomaly face syndromes,” Current Opinion in Pediatrics, vol. 13, no. 5, pp. 465–472, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. F. Jawad, D. M. McDonald-McGinn, E. Zackai, and K. E. Sullivan, “Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome),” Journal of Pediatrics, vol. 139, no. 5, pp. 715–723, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Piliero, A. N. Sanford, D. M. McDonald-McGinn, E. H. Zackai, and K. E. Sullivan, “T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome,” Blood, vol. 103, no. 3, pp. 1020–1025, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Chinen, H. M. Rosenblatt, E. O. Smith, W. T. Shearer, and L. M. Noroski, “Long-term assessment of T-cell populations in DiGeorge syndrome,” Journal of Allergy and Clinical Immunology, vol. 111, no. 3, pp. 573–579, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. F. Lavi, W. Kamchaisatian, J. W. Sleasman et al., “Thymic output markers indicate immune dysfunction in DiGeorge syndrome,” Journal of Allergy and Clinical Immunology, vol. 118, no. 5, pp. 1184–1186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Piliero, A. N. Sanford, D. M. McDonald-McGinn, E. H. Zackai, and K. E. Sullivan, “T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome,” Blood, vol. 103, no. 3, pp. 1020–1025, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Pierdominici, F. Mazzetta, E. Caprini et al., “Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome),” Clinical and Experimental Immunology, vol. 132, no. 2, pp. 323–331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Gennery, D. Barge, J. J. O'Sullivan, T. J. Flood, M. Abinun, and A. J. Cant, “Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome,” Archives of Disease in Childhood, vol. 86, no. 6, pp. 422–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Finocchi, S. Di Cesare, M. L. Romiti et al., “Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome),” Pediatric Allergy and Immunology, vol. 17, no. 5, pp. 382–388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Smith, D. A. Driscoll, B. S. Emanuel, D. M. McDonald-McGinn, E. H. Zackai, and K. E. Sullivan, “Increased prevalence of immunoglobulin a deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome),” Clinical and Diagnostic Laboratory Immunology, vol. 5, no. 3, pp. 415–417, 1998. View at Google Scholar · View at Scopus
  22. A. K. Ryan, J. A. Goodship, D. I. Wilson et al., “Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study,” Journal of Medical Genetics, vol. 34, no. 10, pp. 798–804, 1997. View at Google Scholar · View at Scopus
  23. K. E. Sullivan, D. McDonald-McGinn, and E. H. Zackai, “CD4+ CD25+ T-cell production in healthy humans and in patients with thymic hypoplasia,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 5, pp. 1129–1131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Barthlott, G. Kassiotis, and B. Stockinger, “T cell regulation as a side effect of homeostasis and competition,” Journal of Experimental Medicine, vol. 197, no. 4, pp. 451–460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. McDonald-McGinn, A. Reilly, C. Wallgren-Pettersson et al., “Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/Velocardiofacial syndrome),” American Journal of Medical Genetics, vol. 140, no. 8, pp. 906–909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. S. Kar, B. Ogoe, R. Poole, and D. Meeking, “Di-George syndrome presenting with hypocalcaemia in adulthood: two case reports and a review,” Journal of Clinical Pathology, vol. 58, no. 6, pp. 655–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. Johnston, D. E. Donnelly, P. J. Morrison, and S. J. Hunter, “DiGeorge syndrome presenting as late onset hypocalcaemia in adulthood,” Ulster Medical Journal, vol. 78, no. 3, p. 170, 2009. View at Google Scholar · View at Scopus